PERSPECTIVE THERAPEUTICS, INC. Other Current Liabilities
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Other Current Liabilities of $480.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2024-03-28
- 2023-12-31: Other Liabilities, Current $480.00K.
- 2023-09-30: Other Liabilities, Current $24.00K.
- 2023-06-30: Other Liabilities, Current $20.00K.
- 2023-03-31: Other Liabilities, Current $15.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2023-12-31 | $480.00K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $24.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $20.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $15.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $571.00K 10-K · filed 2024-03-28 | $129.00K 10-KT · filed 2023-05-01 |
| 2022-09-30 | $125.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $120.00K 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $94.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $103.00K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $102.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $100.00K 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $99.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $101.00K 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $94.00K 10-K · filed 2021-09-27 | |
| 2020-03-31 | $87.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $89.00K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $83.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $74.00K 10-K · filed 2020-09-25 | |
| 2019-03-31 | $65.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $55.00K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $45.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $37.00K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $28.00K 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $19.00K 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $11.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $125.00K 10-K · filed 2018-09-26 | |
| 2017-03-31 | $203.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $195.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $189.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $177.00K 10-K · filed 2017-09-28 | |
| 2016-03-31 | $164.54K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $153.50K 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $141.50K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $129.50K 10-K · filed 2016-09-09 | |
| 2015-03-31 | $118.12K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $108.07K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $153.59K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $141.59K 10-K · filed 2015-09-14 | |
| 2014-03-31 | $130.30K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $124.00K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $112.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $100.00K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $88.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $76.00K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $64.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $52.00K 10-K · filed 2013-09-30 | |
| 2012-03-31 | $40.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $132.06K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $116.37K 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $108.06K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |